IL1B and inflammatory bowel disease: In brief, intestinal inflammation in IBD leads to release of pro-inflammatory cytokines, including tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β) [11, 12].